Medicine recalls
|
| |
| Australia: Hydralyte Strawberry Kiwi Effervescent Electrolyte Tablets: Recall due to unacceptable risk in pregnancy |
| |
Therapeutic Goods Administration (TGA) announces that Care Pharmaceuticals Pty Ltd, in consultation with the TGA, is recalling 10 batches of Hydralyte Strawberry Kiwi Effervescent Electrolyte Tablets due to the presence of Carthamus tinctorius (safflower) as an inactive ingredient. The level of exposure of Carthamus tinctorius in this product poses an unacceptable risk if used in pregnancy. The recall affects all batches within the current expiry date (10 batches in total). The affected batch numbers are: L9136/1, L9198/7, L9268/5, L9309/1, L0108/11, L0205/4, L0031/7, L0031/8, L0066/4 and L0311/5.
Hydralyte Strawberry Kiwi Effervescent Electrolyte Tablets is a listed complementary medicine used to relieve the symptoms of dehydration.
The TGA investigation concluded that the safety of Hydralyte Strawberry Kiwi Effervescent Electrolyte Tablets was unacceptable as it may expose consumers to Carthamus tinctorius during pregnancy. Further, the product does not contain the mandatory label warning ‘Do not use if pregnant or likely to become pregnant' due to the inclusion of Carthamus tinctorius as an inactive ingredient. This issue does not affect any other Hydralyte flavours or products.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/hydralyte-strawberry-kiwi-effervescent-electrolyte-tablets
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Saturday, May 22, 2021
Issued at HKT 12:00
|
| |
